previous arrow
next arrow
Slider
Product Image
Winning in their blood, Polyglycan in their joints

Category: Joint & Cartilage Support

Species: Horses, Dogs

Active Ingredients: hyaluronic acid + chondroitin sulfates C4 & C6 + N-acetyl-D-glucosamine sterile solution

prescription required

What is Polyglycan®?

Polyglycan® is a patented formulation of hyaluronic acid, sodium chondroitin sulfate, and N-acetyl-D-glucosamine in a highly viscous aqueous solution for use in horses and dogs. Glucosaminoglycans are important components of extracellular tissue structures, including cartilage and synovial fluid.

Indications

Polyglycan® is indicated for the replacement of lost or damaged synovial fluid. Polyglycan® contains naturally occurring components of the synovia that play a central part in maintaining the homeostatic environment of the joint.

Polyglycan Formats

polyglycan

POLYGLYCAN

  • Supplied in cartons (6 x 10mL vials)
  • Refrigerated product

Each 10mL vial contains:

  • Hyaluronic acid sodium salt50 mg
  • Sodium chondroitin sulfate1000 mg
  • N-acetyl-D-glucosamine1000 mg

Download Data Sheet Safety Sheet

polyglycan-hv

POLYGLYCAN-HV

  • HV = High Viscosity
  • Supplied in individual carton, single syringe label-sealed in a blister tray
  • 2.5 mL prefilled syringes
  • Refrigerated product

Each 2.5mL prefilled syringe contains:

  • Hyaluronic acid sodium salt20 mg
  • Sodium chondroitin sulfate250 mg
  • N-acetyl-D-glucosamine125 mg

Download Data Sheet Safety Sheet

polyglycan-sa

POLYGLYCAN-SA

  • SA = Single Administration or Small Animal
  • Supplied in cartons (6 x 2.5mL vials)
  • Refrigerated product

Each 2.5mL vial contains:

  • Hyaluronic acid sodium salt12.5 mg
  • Sodium chondroitin sulfate250 mg
  • N-acetyl-D-glucosamine250 mg

Download Data Sheet Safety Sheet

Properties

  • Glucosaminoglycans are important components of all extracellular tissue structures including cartilage and synovial fluid.
  • The active components in Polyglycan show viscoelastic and polyionic properties similar in nature to synovial fluid.
  • Patented 3-component formula has demonstrated characteristics beyond any of these components used individually.

Benefits joint

  • Help replenish lost synovial fluid with naturally occurring elements
  • Assists in normalization of synovial fluid viscosity
  • Post-surgical lavage of the joint cavity and surfaces
  • Patented formulation
  • Convenient pre-filled syringe (Polyglycan®-HV)

Consult with your veterinarian if you suspect your horse may have Osteoarthritis or other disease as the clinical signs can vary.

I have continued to use Polyglycan® as a standard postoperative parenteral treatment as well for essentially all of my orthopedics.
I have encountered no adverse effects either locally within the joint or any systemic reactions from either route of administration of Polyglycan®.

Robert J. Hunt, DVM, MS, Diplomate
ACVS Hagyard Equine Medical Institute, Lexington, KY

Veterinarian response to a recently published study & article that raised concerns of Polyglycan® safety if adminstered intravenously.

We’ve used over 50,000 mL of Polyglycan® in our practice giving us a high level of comfort and confidence in its applications.
To date there have been no adverse events to be reported by our clients or our practice.
Through my peer group I have not had conversations to suggest that their experience has been different. In my opinion, application of Polyglycan® has benefitted the joint health and the overall well-being of horses that I have had the privilege to be the caregiver.

Chris Morrow, DVM
Mobile Veterinary Practice, Amarillo, TX

Veterinarian response to a recently published study & article that raised concerns of Polyglycan® safety if adminstered intravenously.

the findings of this study do not correlate with what I have seen in 9 years of using this product in a clinical setting, and I disagree with the conclusion that Polyglycan® may be harmful to the joint when administered IV.
Although the experimental model used in this study is the best model available for measuring changes in the joint environment using different medications, in my opinion, the model, as an acute chip fracture, does not replicate the disease process that I see in practice. Hopefully, the findings of this article will lead to new experiments & new discoveries about the processes involved with osteoarthritis.

C.R. Johnson, DVM, MS, DACVS
Equine Surgical Services, Versailles, KY

Veterinarian response to a recently published study & article that raised concerns of Polyglycan® safety if adminstered intravenously.

previous arrowprevious arrow
next arrownext arrow
Slider

Pack Sizes

List No.Pack SizeCase Size
Polyglycan
(1POL007)
6x10mL vials40
Polyglycan-HV
(1POL008)
2.5 mL prefilled / 5mL syringe40
Polyglycan-SA
(1POL009)
6 x 2.5 mL vials60